This edition’s highlight:
Pulmonary hypertension
Pulmonary hypertension is a cause for major morbidity and mortality, and while therapeutic options are evolving, they are still limited and difficult to administer. Following the publication of these new guidelines at ESC Congress 2022, we have three on-demand webinars on this subject.
The first, which accompanies the guidelines and is part of the 2022 ESC Clinical Practice Guidelines Series, covers novelties in pulmonary hypertension, diagnosis and phenotyping. Two further webinars delve in more detail into the practicalities of diagnosis and management of patients with pulmonary hypertension: Part 1 addresses differential diagnosis, PAH therapy, and PH associated with left heart or lung diseases; in Part 2, gain a better understanding of the specific aspects of congenital heart disease, chronic thromboembolic PH, and the patient's voice.
What is the individual patient's risk? complexities of clinical decision-making |
Monday, 16 January |
||||
Hyperkalemia in heart failure: unravelling the risk and therapeutic options |
Wednesday, 18 January |
||||
|
|
||||
|
Tuesday, 31 January |
||||
The electrocardiogram in the diagnosis and risk stratification of primary arrhythmic syndromes Join Assoc. Prof. E. Arbelo, and Profs. V. Probst and A. Sarkozy. Organised by the European Heart Rhythm Association (EHRA). |
Wednesday, 1 February |
||||
Three-dimensional transoesophageal echocardiography: how to use and when to use in valvular heart disease Join Prof. R. Hahn and Drs. N. Ajmone Marsan, A. Berrebi, and F. Fulvio Faletra. Organised by the European Association of Cardiovascular Imaging (EACVI). |
Friday, 3 February |
||||
|
Wednesday, 8 February |
||||
|
Thursday, 16 February |
Webinars are now available on ESC 365 |
Our Diversity Is Our Strength |